About Deborah Wittman
Form D filings for Triopsy Medical from 2020 to 2024 list Deborah Wittman as director.
Deborah Wittman first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Deborah Wittman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Deborah Wittman works with at each company, as listed on that company's latest Form D.
Triopsy Medical, Inc. · Form D, Feb 28, 2024
RL
Richard Larson
Director
DB
David Bostwick
Executive officer and director
JL
James Lousararian
Director
Brad Buscher
Executive Chairman
JH
John Harper
Director
MM
Michael Montag
Director